Cost–Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France

Abstract Introduction The aim of the current study is to estimate the cost-effectiveness of adjuvant treatment with nivolumab relative to clinically relevant comparators in adult patients with melanoma with lymph node involvement or metastatic disease who have undergone complete resection from a Fre...

Full description

Bibliographic Details
Main Authors: Bruno Bregman, Siguroli Teitsson, Isabella Orsini, François-Emery Cotté, Adenike Amadi, Andriy Moshyk, Stéphane Roze, Anne-Françoise Gaudin
Format: Article
Language:English
Published: Adis, Springer Healthcare 2020-09-01
Series:Dermatology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s13555-020-00446-z